Effects of the 5-HT2C/2B antagonist SB 206553 on hyperactivity induced by cocaine

被引:74
|
作者
McCreary, AC [1 ]
Cunningham, KA [1 ]
机构
[1] Univ Texas, Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA
关键词
cocaine; hyperactivity; SB; 206553; serotonin; 5-HT2C; 5-HT2B;
D O I
10.1016/S0893-133X(98)00087-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Serotonin (5-HT) appears to play a modulatory role in the behavioral effects of cocaine, although the impact of 5-HT2C receptors in this control has not been fully established. The aim of the present study was to establish whether acute pretreatment with the selective 5-HT2C/2B antagonist SB 206553 (1, 2, and 4 mg/kg IP) altered hyperactivity induced by cocaine (15 mg/kg, IP) using an open field activity system which recorded central, peripheral, and rearing activity. Pretreatment with 1 and 2 mg/kg of SB 206553 attenuated cocaine-induced central and peripheral activity, respectively; rearing was also attenuated by the latter dose. However, the 4-mg/kg dose of SB 206553 significantly enhanced the effects of cocaine on peripheral activity. Based upon the present observations and an interpretation of previous research to implicate 5-HT2C receptor control of the dopamine (DA) mesoaccumbens pathways in behavior, a thorough and systematic analysis of the role of 5-HT2C (and 5-HT2B) receptors in psychostimulant-induced behaviors is warranted. (C) 1999 American College of Neuropsychopharmacology. Published by Elsevier Science Inc.
引用
收藏
页码:556 / 564
页数:9
相关论文
共 50 条
  • [1] Effects of the 5-HT2C/2B Antagonist SB 206553 on Hyperactivity Induced by Cocaine
    Andrew C McCreary
    Kathryn A Cunningham
    Neuropsychopharmacology, 1999, 20 : 556 - 564
  • [2] Effects of SB 206553, a 5-HT2C/2B receptor antagonist, in a marmoset conflict model of anxiety
    Bright, F
    Cilia, J
    Piper, D
    Blackburn, T
    Kennett, G
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 : P153 - P153
  • [3] The novel 5-HT2C/2B receptor antagonist SB206553 is a potent and surmountable antagonist at cloned human receptors
    Gager, TL
    Holland, V
    Thomas, DR
    Blackburn, TP
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 : P133 - P133
  • [4] THE 5-HT2C/2B RECEPTOR ANTAGONIST SB-200646A IS A POTENT AND SELECTIVE ANTAGONIST OF THE HUMAN 5-HT2C RECEPTOR
    WOOD, MD
    GAGER, TL
    THOMAS, DR
    NEWTON, RA
    PHIPPS, SL
    ELLIOTT, JM
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 : P155 - P155
  • [5] Comparative modulation of hippocampal 5-HT release by the 5-HT2C receptor antagonist SB 206553 and paroxetine
    Thorn, L
    Routledge, C
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 : P257 - P257
  • [6] In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties
    Kennett, GA
    Wood, MD
    Bright, F
    Cilia, J
    Piper, DC
    Gager, T
    Thomas, D
    Baxter, GS
    Forbes, IT
    Ham, P
    Blackburn, TP
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 (03) : 427 - 434
  • [7] IN-VIVO PROPERTIES OF SB 200646A, A 5-HT2C/2B RECEPTOR ANTAGONIST
    KENNETT, GA
    WOOD, MD
    GLEN, A
    GREWAL, S
    FORBES, I
    GADRE, A
    BLACKBURN, TP
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 111 (03) : 797 - 802
  • [8] FUNCTIONAL ANTAGONISTIC AND ANXIOLYTIC EFFECTS OF THE 5-HT2C/2B RECEPTOR ANTAGONIST, SB-200646A, IN RODENTS
    BILL, DJ
    FORSTER, EA
    GREWAL, SS
    FLETCHER, A
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 : P217 - P217
  • [9] The selective 5-HT2C/2B receptor antagonist SB221284 enhances the behavioural and biochemical effects of morphine in mice
    Garrett, L
    Barton, C
    Bristow, LJ
    Hutson, PH
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 : U124 - U124
  • [10] SB 242084:: A selective 5-HT2C receptor antagonist
    Di Matteo, V
    Di Giovanni, G
    Esposito, E
    CNS DRUG REVIEWS, 2000, 6 (03): : 195 - 205